Cost effectiveness is becoming an increasingly important factor for stakeholders faced with
decisions about adding a new vaccine into national immunization programmes versus …

Varicella is a common vaccine-preventable disease that usually presents as a mild disorder
but can lead to severe complications. Before the implementation of universal varicella …

Background Though the disease burden of varicella in Europe has been reported
previously, the economic burden is still unknown. This study estimated the economic burden …

Background: The Shingles Prevention Study showed that a varicella-zoster virus (VZV)
vaccine administered to adults 60 years of age or older reduced the incidence of herpes …

The history of polio vaccination in the United States spans 50 years and includes different
phases of the disease, multiple vaccines, and a sustained significant commitment of …

The use of vaccines to prevent diseases in children, adults, and the elderly results in fewer
medical visits, diagnostic tests, treatments, and hospitalisations, which leads to substantial …

Background: Combination vaccines against common childhood diseases are widely used,
provide an improved coverage, are more convenient and are more cost-effective than …

Objectives This study carried out a systematic literature review of economic evaluations of
varicella vaccination programmes from the earliest publication to the present day, including …

Objective The objectives of this review were to identify vaccine economic evaluations that
include herd immunity and describe the methodological approaches used. Methods We …

Background A systematic review was conducted to assess the cost-effectiveness of routine
varicella and herpes zoster (HZ) vaccination in high-income countries estimated by …